These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28727913)

  • 1. Alpha-l-Fucosidase Immunoassay for Early Detection of Hepatocellular Carcinoma.
    Waidely E; Al-Youbi AO; Bashammakh AS; El-Shahawi MS; Leblanc RM
    Anal Chem; 2017 Sep; 89(17):9459-9466. PubMed ID: 28727913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbon dots and gold nanoparticles based immunoassay for detection of alpha-L-fucosidase.
    Mintz K; Waidely E; Zhou Y; Peng Z; Al-Youbi AO; Bashammakh AS; El-Shahawi MS; Leblanc RM
    Anal Chim Acta; 2018 Dec; 1041():114-121. PubMed ID: 30340683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum alpha-L-fucosidase activity and early detection of hepatocellular carcinoma: a prospective study of patients with cirrhosis.
    Giardina MG; Matarazzo M; Morante R; Lucariello A; Varriale A; Guardasole V; De Marco G
    Cancer; 1998 Dec; 83(12):2468-74. PubMed ID: 9874450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum alpha-L-fucosidase. A useful marker in the diagnosis of hepatocellular carcinoma.
    Giardina MG; Matarazzo M; Varriale A; Morante R; Napoli A; Martino R
    Cancer; 1992 Sep; 70(5):1044-8. PubMed ID: 1381268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum alpha-L-fucosidase activity and tumor size in hepatocellular carcinoma.
    Takahashi H; Saibara T; Iwamura S; Tomita A; Maeda T; Onishi S; Yamamoto Y; Enzan H
    Hepatology; 1994 Jun; 19(6):1414-7. PubMed ID: 7514563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical performance of α-L-fucosidase for early detection of hepatocellular carcinoma.
    Xing H; Qiu H; Ding X; Han J; Li Z; Wu H; Yan C; Li H; Han R; Zhang H; Li C; Wang M; Wu M; Shen F; Zheng Y; Yang T
    Biomark Med; 2019 May; 13(7):545-555. PubMed ID: 31140827
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnostic value of alpha-L-fucosidase for hepatocellular carcinoma: a meta-analysis.
    Gan Y; Liang Q; Song X
    Tumour Biol; 2014 May; 35(5):3953-60. PubMed ID: 24395655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum alpha-L-fucosidase. A more sensitive marker for hepatocellular carcinoma?
    Marotta F; Chui DH; Safran P; Zhang SC
    Dig Dis Sci; 1991 Jul; 36(7):993-7. PubMed ID: 1712699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic significance of the determination of serum alpha-L-fucosidase in primary hepatocellular carcinoma].
    Yu ZW; Duan FL; Yang XW
    Zhonghua Nei Ke Za Zhi; 1989 Jul; 28(7):394-6, 442. PubMed ID: 2556248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel fluorescence method for detection of α-L-fucosidase based on CdTe quantum dots.
    Chen Z; Ren X; Meng X; Zhang Y; Chen D; Tang F
    Anal Chem; 2012 May; 84(9):4077-82. PubMed ID: 22486298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-L-fucosidase as a serum marker of hepatocellular carcinoma in southern African blacks.
    Bukofzer S; Stass PM; Kew MC; de Beer M; Groeneveld HT
    Br J Cancer; 1989 Mar; 59(3):417-20. PubMed ID: 2467686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced detection of hepatocellular carcinoma.
    el-Houseini ME; Mohammed MS; Elshemey WM; Hussein TD; Desouky OS; Elsayed AA
    Cancer Control; 2005 Oct; 12(4):248-53. PubMed ID: 16258497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-L-fucosidase as a tumour marker of hepatocellular carcinoma.
    Fawzy Montaser M; Amin Sakr M; Omar Khalifa M
    Arab J Gastroenterol; 2012 Mar; 13(1):9-13. PubMed ID: 22560818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum alpha-L-fucosidase: a new marker for the diagnosis of primary hepatic carcinoma?
    Deugnier Y; David V; Brissot P; Mabo P; Delamaire D; Messner M; Bourel M; Legall JY
    Hepatology; 1984; 4(5):889-92. PubMed ID: 6207091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-L-fucosidase as a serum marker of hepatocellular carcinoma in Thailand.
    Tangkijvanich P; Tosukhowong P; Bunyongyod P; Lertmaharit S; Hanvivatvong O; Kullavanijaya P; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 1999 Mar; 30(1):110-4. PubMed ID: 10695798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A preliminary study on serum alpha-L-fucosidase assay in the diagnosis of hepatocellular carcinoma].
    Shen W; Shen DM
    Zhonghua Nei Ke Za Zhi; 1989 Jul; 28(7):397-9, 442-3. PubMed ID: 2480210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of the serum measurement of alpha-L-fucosidase in the diagnosis of hepatocarcinoma].
    López Vivancos J; Segura RM; Oliva G; Vives L; Pascual C; Vilaseca J
    Med Clin (Barc); 1989 Sep; 93(7):241-3. PubMed ID: 2478845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of the development of hepato-cellular-carcinoma in patients with liver cirrhosis by the serial determinations of serum alpha-L-fucosidase activity.
    Ishizuka H; Nakayama T; Matsuoka S; Gotoh I; Ogawa M; Suzuki K; Tanaka N; Tsubaki K; Ohkubo H; Arakawa Y; Okano T
    Intern Med; 1999 Dec; 38(12):927-31. PubMed ID: 10628928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum and tissue alpha-L-fucosidase activity in the pre-clinical and clinical stages of hepatocellular carcinoma.
    Hutchinson WL; Johnson PJ; Du MQ; Williams R
    Clin Sci (Lond); 1991 Aug; 81(2):177-82. PubMed ID: 1716188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum protein biomarkers relevant to hepatocellular carcinoma and their detection.
    Waidely E; Al-Yuobi AR; Bashammakh AS; El-Shahawi MS; Leblanc RM
    Analyst; 2016 Jan; 141(1):36-44. PubMed ID: 26606739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.